Litigation

1

Kluwer Patent Blog published the post by Kirill Osipov

The new post by Kirill Osipov, the Head of Legal Department at ARS-Patent, is a continuation of studying the issue of cascading divisional applications, which was described in the previous post, and has further development in connection with the consideration of two court cases, Nos. SIP-570/2022 and SIP-552/2022. You can read the post on Kluwer […]

Read more

2

Reimbursement of expenses when considering the disputes in Rospatent

In accordance with the new Federal Law No. 390361-8 of January 30, 2024, with proposed amendments to Article 1248 of the Civil Code of the Russian Federation, when considering the disputes in administrative proceedings in the Chamber of Patent Disputes (department of Rospatent) with regard to patents, trademarks, utility models and other IP objects, reimbursement […]

Read more

3

A new post in Kluwer Patent Blog

The issue of cascading divisional applications is the theme of a new post by Kirill Osipov, the Head of Legal Department at ARS-Patent, published on the Kluwer Patent Blog. Read Kirill’s study of the court case SIP-570/2022 and its conclusions via the link.

Read more

4

Kirill Osipov’s article published in the Newsletter of the AIPLA Chemical Practice Committee

An article by Kirill Osipov, the Head of Legal Department at ARS-Patent, has been recently published in the Newsletter “Chemical Practice Chronicles” of the American Intellectual Property Law Association (AIPLA). The article discusses recent legal developments in Russia concerning the patenting of new derivatives of known substances as another attempt to find a balance of […]

Read more

5

Successful representation of the client’s interests in a trademark cancellation case

ARS-Patent represented the interests before the Court for Intellectual Property Rights of the German company AMAZONEN-WERKE Н. Dreyer SE & Co. KG, a large-scale producer of agricultural machinery. In the result of the examination of the international registration by the Russian Patent and Trademark Office, our client received a refusal on legal protection on the […]

Read more

6

Kirill Osipov’s article in INNOVATE Magazine of AIPLA

An article by Kirill Osipov, the Head of Legal Department of ARS-Patent, was published in INNOVATE Magazine of the American Intellectual Property Law Association (AIPLA). In the article named IP in Russia: “dura lex, sed lex” is still, Kirill provides the studies of the recent court cases and concludes that in the current political situation, […]

Read more

7

ARS-Patent protected the interests of the client in a trademark dispute

The specialists of ARS-Patent represented the interests of a company Max Weishaupt GmbH, a German producer of heating systems and equipment, as a defendant in a trademark cancellation dispute. Our clients’ trademark was subject to cancellation due to non-use. In the course of the legal proceedings, our company managed to reach an amicable agreement with […]

Read more

8

ARS-Patent Highly Recommended by IAM Patent 1000

We are delighted to be recognized by the 2022 edition of IAM Patent 1000: The World’s Leading Patent Professionals, which identifies the top patent professionals in key jurisdictions around the globe. ARS-Patent has been awarded the rating “Highly Recommended” in the category Prosecution and Silver band in the category Litigation and transactions. The recommended patent […]

Read more

9

Transactions in connection with a patent, trademark, copyright, or other form of intellectual property protection in Russia and U.S.

The U.S. Department of the Treasury’s Office of Foreign Assets Control (“OFAC”) issued a General License No. 31 dated May 5, 2022 which makes an exception to the previously adopted sanctions related to transactions made in connection with patents, trademarks, copyright and other form of intellectual property. As for now, the following transactions are authorized: […]

Read more

10

ARS-Patent protected Novo Nordisk A/S’s interests in a patent dispute

ARS-Patent represented the interests of Novo Nordisk A/S in the patent dispute over the Rospatent’s decision on extension of the validity term of a patent related to Insulin degludec owned by Novo Nordisk A/S. Recently, a request of the plaintiff (Geropharm LLC) for the cassation appeal to be considered by the Court Board of the […]

Read more

Next page

MEET WITH US

ARS-Patent will attend the APAA 2025 in Kuala Lumpur

2025-10-03

We are pleased to announce that ARS-Patent will be a part of the upcoming global IP event APAA 2025, which is the 21st General Assembly and 77th & 78t...

Read more
ARS-Patent at AIPPI World Congress 2025 in Yokohama

2025-08-18

The AIPPI World Congress 2025, which will be held in Yokohama, Japan, from September 13-16, will be a significant international gathering for intellec...

Read more

See all Events

Back top